Century Therapeutics raises $60M for autoimmune research, acquires Clade Therapeutics for $35M.

Century Therapeutics raises $60M in funding led by Bain Capital Life Sciences to expand research into autoimmune diseases. The company also acquired Clade Therapeutics for $35M, gaining preclinical programs and technology to engineer stem cell-derived medicines. The deals aim to study if cell therapy, proven to treat certain blood cancers, can also manage autoimmune conditions like lupus.

Articles

Benzinga

BioPharma Dive

Biztoc

Street Insider

www.investegate.co.uk:443

Market Screener

Street Insider

-- show less --

Related Stories